HoFH: Achieving Earlier Diagnosis and Optimizing Outcomes Using Non‐statin Therapies
Released On
August 2, 2023
Expires On
August 2, 2024
Media Type
Internet
Completion Time
60 minutes
Specialty
Cardiology, Endocrinology, Primary Care
Topic(s)
Cardiovascular Disease
This activity is jointly provided by Global Education Group and PlatformQ Health Education, LLC, in collaboration with American Society for Preventive Cardiology (ASPC)..
Acknowledgement
This activity is supported by an independent medical education grant from Regeneron Pharmaceuticals, Inc.
Credit Available
- Physicians - maximum of 1.0 AMA PRA Category 1 Credit™
Target Audience
The educational design of this activity addresses the needs of cardiologists, endocrinologists, and primary care practitioners.
Program Overview
Establishing an early diagnosis of homozygous familial hypercholesterolemia (HoFH) is important to promptly initiate treatment and lower low‐density lipoprotein cholesterol (LDL‐C) and risk of progressive atherosclerotic cardiovascular disease. HoFH is a difficult‐to‐treat disorder with most patients requiring multiple lipid-lowering therapies and many not achieving target LDL‐C levels.
Join an expert panel of cardiologists and lipidologists to review recommended screening and diagnostic techniques for HoFH. Clinicians will learn about new therapies and indications, including selection and sequencing of HoFH treatments. Panelists will also share proven patient-communication techniques to enhance shared decision-making and align HCP and patient perspectives and goals.
Do you have patients at risk for or with HoFH who could use education on effective screening, treatments, and coping strategies? Direct your patients to MedLive.com to access the activity, “Navigating HoFH: Understanding Your Diagnosis and Treatment Options and Working with the Care Team.”
Learning Objectives
After completing this activity, the participant should be better able to:
- Identify recommended screening approaches and diagnostic criteria for HoFH
- Discuss strategies for incorporating therapies for HoFH into a patient‐centered treatment plan
- Describe the mechanisms of action and efficacy and safety data for newer agents for HoFH, including emerging indications
Faculty
Seth S. Martin, MD, MHS, FAHA, FACC, FASPC
Professor of Medicine
Director of the Advanced Lipid Disorders Program and Digital Health Lab
Ciccarone Center for the Prevention of Cardiovascular Disease
Johns Hopkins School of Medicine
Pamela B. Morris, MD, FACC, FAHA, FASPC, FNLA
Professor of Medicine, Cardiology
Paul V. Kramer Endowed Chair in Cardiovascular Disease Prevention
Director, Seinsheimer Cardiovascular Health Program
Trustee, American College of Cardiology
The Medical University of South Carolina
Accreditation Statement:
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Global Education Group (Global) and PlatformQ Health Education, LLC. Global is accredited by the ACCME to provide continuing medical education for physicians.
Credit Designation
Physician Credit Designation
Global Education Group designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Disclosures of Relevant Financial Relationship(s)
Global Education Group (Global) adheres to the policies and guidelines, including the Standards for Integrity and Independence in Accredited CE, set forth to providers by the Accreditation Council for Continuing Medical Education (ACCME) and all other professional organizations, as applicable, stating those activities where continuing education credits are awarded must be balanced, independent, objective, and scientifically rigorous. All persons in a position to control the content of an accredited continuing education program provided by Global are required to disclose all financial relationships with any ineligible company within the past 24 months to Global. All financial relationships reported are identified as relevant and mitigated by Global in accordance with the Standards for Integrity and Independence in Accredited CE in advance of delivery of the activity to learners. The content of this activity was vetted by Global to assure objectivity and that the activity is free of commercial bias.
All relevant financial relationships have been mitigated.
The faculty reported the following relevant financial relationships with ineligible companies related to the content of this educational activity:
The planners and managers at Global Education Group have no relevant financial relationships to disclose.
The planners and managers at PlatformQ Health Education have no relevant financial relationships to disclose.
Instruction for Participaton and Credit:
Estimated Time to Complete
This activity should take approximately 60 minutes to complete.
Instruction to Receive Credit
In order to receive credit for this activity, the participant must (1) read the target audience, learning objectives, and disclosure statements, (2) complete the educational activity online, and (3) complete the post-test and activity evaluation. To receive AMA PRA Category 1 Credits™, participants must receive a score of 70% on the post-test.
Fee Information & Refund/Cancellation Policy
There is no fee for this educational activity.
Course Viewing Requirements
Hardware/Software Requirements
Participants will need a computer with a recent version of Adobe Flash installed, as well as an internet connection sufficient for streaming media.
Disclosure of Unlabeled Use
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. Global Education Group (Global) and PlatformQ Health Education, LLC do not recommend the use of any agent outside of the labeled indications.
The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of any organization associated with this activity. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Disclaimer
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed in this activity should not be used by clinicians without evaluation of patient conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.
Contact Information
Accreditation Support
For information about the physician accreditation of this program, please contact Global at 303-395-1782 or cme@globaleducationgroup.com.
Technical Support:
For any technical issues or issues with your CME Certificate, please contact CardioCareLive at 877-394-1306 or at Support@CardioCareLive.com
PlatformQ Health Privacy Policy
By clicking “Start Activity” you are agreeing to PlatformQ Health’s privacy policy. PlatformQ Health takes your privacy very seriously. The full Privacy Policy found here describes (i) the types of information we collect from you when you visit our Site; (ii) how we use the information we collect; (iii) with whom and why we share it; and (iv) the choices we offer regarding our use of the information. We also describe how to contact us about our privacy practices.
Information we collect is primarily used to communicate with program participants, award CME/CE credits, manage user accounts, recommend relevant programs and perform data analysis to inform educational outcomes.
In plain English, here is what we affirm:
- You can change your registration profile at any time from our “Profile” page
- To request any of these changes without logging in, please call us at 1 (877) 394-1306 or email us at support@PlatformQHealth.com
- You can end your association with PlatformQ Health at any time
- PlatformQ Health does not spam, nor we do we rent or sell our email list in whole or in part. Any program-related data sharing is for engagement verification and opt-in based further education
- EU citizens can request a complete record of their account and/or request to have their personal data expunged by contacting support@PlatformQHealth.com with the subject line “Data Request”
You acknowledge and agree that by beginning this activity, you have affirmatively agreed to this Privacy Policy and consented to receiving electronic messages in conformance with this Privacy Policy. Please read the full privacy policy located at: www.platformqhealth.com/privacy-policy/.